Forbion Growth Opportunities Fund
Venture Capital
Forbion Growth Opportunities Fund targets late-stage biopharma companies in Europe and North America with clear clinical value.
Growth
Late Stage
Biotech
Life Sciences
- Headquarters
- Naarden, Netherlands
- Founded
- 2021
- Website
- forbion.com
- Last Investment
- Nov 2023
- Geographic Focus
- Europe, North America
Investment Thesis
Invests in differentiated late-stage assets with strong strategic relevance for clinical development.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account